Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ICU MEDICAL INC/DEICUI · Entity 2385 | VP, General Counsel | September 03, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ICU MEDICAL INC/DE
Report date September 03, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,604 |
Ending reported balance
After 2026-09-03 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-09-03 · Sale · Disposed 2,202 · Balance 17,258 F1: The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.20 to $168.145, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Row 2 · 2026-09-03 · Sale · Disposed 1,238 · Balance 16,020 F1: The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $168.21 to $169.15, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Row 3 · 2026-09-03 · Sale · Disposed 724 · Balance 15,296 F1: The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $169.5 to $169.665, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Row 4 · 2026-09-03 · Sale · Disposed 692 · Balance 14,604 F1: The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.775 to $171.69, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.20 to $168.145, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $168.21 to $169.15, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $169.5 to $169.665, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.775 to $171.69, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 03, 2026 Filed Sep 3, 2026 22:29 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 692 | $171.52 | $118,688.38 |
DisclosureSEC source: 0001669639-26-000004 · edgardoc.xml · nonDerivative · entry 4 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,604 F1 · shares: The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.775 to $171.69, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 03, 2026 Filed Sep 3, 2026 22:29 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 724 | $169.53 | $122,736.46 |
DisclosureSEC source: 0001669639-26-000004 · edgardoc.xml · nonDerivative · entry 3 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,296 F1 · shares: The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $169.5 to $169.665, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 03, 2026 Filed Sep 3, 2026 22:29 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 1,238 | $168.44 | $208,522.78 |
DisclosureSEC source: 0001669639-26-000004 · edgardoc.xml · nonDerivative · entry 2 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,020 F1 · shares: The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $168.21 to $169.15, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 03, 2026 Filed Sep 3, 2026 22:29 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 2,202 | $167.67 | $369,202.73 |
DisclosureSEC source: 0001669639-26-000004 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,258 F1 · shares: The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.20 to $168.145, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| May 14, 2026 Filed May 15, 2026 16:19 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 2,447 | $124.08 | $303,623.76 |
DisclosureSEC source: 0001669639-26-000003 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,460 F1 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| March 15, 2026 Filed Mar 16, 2026 20:31 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 5,700 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001669639-26-000002 · edgardoc.xml · derivative · entry 6 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,700 shares Expires 2026-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F5 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F2 · shares: Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein. Read SEC document |
| March 15, 2026 Filed Mar 16, 2026 20:31 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 1,624 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001669639-26-000002 · edgardoc.xml · derivative · entry 5 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,624 shares Expires 2026-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: These securities are Restricted Stock Units. F4 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. Read SEC document |
| March 15, 2026 Filed Mar 16, 2026 20:31 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 897 | $125.85 | $112,887.45 |
DisclosureSEC source: 0001669639-26-000002 · edgardoc.xml · nonDerivative · entry 4 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,907 Read SEC document |
| March 15, 2026 Filed Mar 16, 2026 20:31 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,624 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-26-000002 · edgardoc.xml · nonDerivative · entry 3 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,804 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: These securities are Restricted Stock Units. Read SEC document |
| March 15, 2026 Filed Mar 16, 2026 20:31 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 3,150 | $125.85 | $396,427.50 |
DisclosureSEC source: 0001669639-26-000002 · edgardoc.xml · nonDerivative · entry 2 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,180 F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). Read SEC document |
| March 15, 2026 Filed Mar 16, 2026 20:31 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 5,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-26-000002 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,330 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F2 · shares: Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein. Read SEC document |
| March 08, 2026 Filed Mar 9, 2026 20:18 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 23,917 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001669639-26-000001 · edgardoc.xml · derivative · entry 9 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,917 shares Expires 2024-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F7 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F2 · shares: Represents the settlement of performance stock units granted on 3/8/2024. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 250% of target, resulting in the acquisition of the shares reported herein. Read SEC document |
| March 08, 2026 Filed Mar 9, 2026 20:18 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 3,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-26-000001 · edgardoc.xml · derivative · entry 8 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,886 Underlying: Common Stock · 3,189 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 08, 2026 Filed Mar 9, 2026 20:18 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 1,762 | $132.00 | $232,584.00 |
DisclosureSEC source: 0001669639-26-000001 · edgardoc.xml · nonDerivative · entry 6 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,630 Read SEC document |
| March 08, 2026 Filed Mar 9, 2026 20:18 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 3,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-26-000001 · edgardoc.xml · nonDerivative · entry 5 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,392 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 08, 2026 Filed Mar 9, 2026 20:18 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 13,221 | $132.00 | $1,745,172.00 |
DisclosureSEC source: 0001669639-26-000001 · edgardoc.xml · nonDerivative · entry 4 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,203 Read SEC document |
| March 08, 2026 Filed Mar 9, 2026 20:18 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 23,917 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-26-000001 · edgardoc.xml · nonDerivative · entry 3 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,424 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents the settlement of performance stock units granted on 3/8/2024. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 250% of target, resulting in the acquisition of the shares reported herein. Read SEC document |
| March 07, 2026 Filed Mar 9, 2026 20:18 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 2,348 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-26-000001 · edgardoc.xml · derivative · entry 7 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,075 Underlying: Common Stock · 2,348 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 07, 2026 Filed Mar 9, 2026 20:18 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 1,297 | $132.00 | $171,204.00 |
DisclosureSEC source: 0001669639-26-000001 · edgardoc.xml · nonDerivative · entry 2 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,507 Read SEC document |
| March 07, 2026 Filed Mar 9, 2026 20:18 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 2,348 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-26-000001 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,804 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| November 11, 2025 Filed Nov 12, 2025 15:55 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 930 | $142.35 | $132,380.85 |
DisclosureSEC source: 0001669639-25-000007 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,456 F1 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| May 30, 2025 Filed May 30, 2025 18:34 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 700 | $133.62 | $93,537.08 |
DisclosureSEC source: 0001669639-25-000005 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,386 F1 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 00:12 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 1,624 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001669639-25-000003 · edgardoc.xml · derivative · entry 3 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,624 Underlying: Common Stock · 1,624 shares Expires 2026-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. These awards were legally granted on March 15, 2023 but were subject to shareholder approval on May 17, 2023. F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 00:12 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 898 | $143.45 | $128,818.10 |
DisclosureSEC source: 0001669639-25-000003 · edgardoc.xml · nonDerivative · entry 2 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,086 Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 00:12 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,624 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-25-000003 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,984 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 08, 2025 Filed Mar 11, 2025 00:17 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 3,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-25-000002 · edgardoc.xml · derivative · entry 7 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,423 Underlying: Common Stock · 3,189 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 08, 2025 Filed Mar 11, 2025 00:17 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 1,759 | $141.97 | $249,725.23 |
DisclosureSEC source: 0001669639-25-000002 · edgardoc.xml · nonDerivative · entry 4 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,360 Read SEC document |
| March 08, 2025 Filed Mar 11, 2025 00:17 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 3,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-25-000002 · edgardoc.xml · nonDerivative · entry 3 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,119 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 00:17 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 7,044 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-25-000002 · edgardoc.xml · derivative · entry 6 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,612 Underlying: Common Stock · 7,044 shares Expires not disclosed F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 00:17 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 1,073 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001669639-25-000002 · edgardoc.xml · derivative · entry 5 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,073 shares Expires 2025-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 00:17 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 625 | $141.97 | $88,731.25 |
DisclosureSEC source: 0001669639-25-000002 · edgardoc.xml · nonDerivative · entry 2 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,930 Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 00:17 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,073 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-25-000002 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| August 08, 2024 Filed Aug 8, 2024 20:56 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 2,050 | $144.11 | $295,425.91 |
DisclosureSEC source: 0001669639-24-000003 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,482 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.48 to $145.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 20:44 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 1,624 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001669639-24-000002 · edgardoc.xml · derivative · entry 3 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,248 Underlying: Common Stock · 1,624 shares Expires 2026-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. These awards were legally granted on March 15, 2023 but were subject to shareholder approval on May 17, 2023. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 20:44 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 890 | $98.08 | $87,291.20 |
DisclosureSEC source: 0001669639-24-000002 · edgardoc.xml · nonDerivative · entry 2 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,532 Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 20:44 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,624 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-24-000002 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,422 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:24 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 2,273 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001669639-24-000001 · edgardoc.xml · derivative · entry 11 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,273 shares Expires 2024-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F7 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F9 · derivative.exercise_date: These PRSUs were granted on March 8, 2021. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 8 of the first, second, and third year following the year of grant. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:24 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 9,568 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-24-000001 · edgardoc.xml · derivative · entry 9 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,568 Underlying: Common Stock · 9,568 shares Expires not disclosed F1 · security: These securities are Restricted Stock Units. F4 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F5 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F6 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:24 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 1,246 | $104.52 | $130,231.92 |
DisclosureSEC source: 0001669639-24-000001 · edgardoc.xml · nonDerivative · entry 7 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,798 Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:24 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 2,273 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-24-000001 · edgardoc.xml · nonDerivative · entry 6 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU). Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:24 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 3,300 | $104.57 | $345,088.26 |
DisclosureSEC source: 0001669639-24-000001 · edgardoc.xml · nonDerivative · entry 5 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,771 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.54 to $104.84, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 20:24 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 6,436 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001669639-24-000001 · edgardoc.xml · derivative · entry 10 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,436 shares Expires 2024-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F7 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F8 · derivative.exercise_date: These PRSUs were granted on March 7, 2022 and had a 2-year cliff-vest performance period subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 200% of the original grant. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 20:24 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 1,073 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001669639-24-000001 · edgardoc.xml · derivative · entry 8 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,073 Underlying: Common Stock · 1,073 shares Expires 2025-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F4 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F5 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F6 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 20:24 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 3,529 | $105.39 | $371,921.31 |
DisclosureSEC source: 0001669639-24-000001 · edgardoc.xml · nonDerivative · entry 4 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,071 Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 20:24 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 6,436 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-24-000001 · edgardoc.xml · nonDerivative · entry 3 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU). Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 20:24 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 587 | $105.39 | $61,863.93 |
DisclosureSEC source: 0001669639-24-000001 · edgardoc.xml · nonDerivative · entry 2 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,164 Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 20:24 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,073 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-24-000001 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,751 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| May 17, 2023 Filed May 18, 2023 17:31 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 4,872 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001669639-23-000004 · edgardoc.xml · derivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,872 Underlying: Common Stock · 4,872 shares Expires 2026-03-15 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. These awards were legally granted on March 15, 2023 but were subject to shareholder approval on May 17, 2023. Read SEC document |
| April 11, 2023 Filed Apr 11, 2023 18:11 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 250 | $175.00 | $43,750.00 |
DisclosureSEC source: 0001669639-23-000003 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,678 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2022. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| April 05, 2023 Filed Apr 5, 2023 21:07 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 458 | $170.00 | $77,860.00 |
DisclosureSEC source: 0001669639-23-000002 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,928 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2022. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.